ANAVEX LIFE SCIENCES CORP. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$3.02 thousand for the 12-month period ending 2014-09-30, per its 10-K filed 2016-12-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2016-12-14
- ANAVEX LIFE SCIENCES CORP. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$3.02K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|
| 2014-09-30 | -$3.02K 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |